4//SEC Filing
Chan Heng Fai Ambrose 4
Accession 0001641172-25-003021
CIK 0001834105other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 5:18 PM ET
Size
5.7 KB
Accession
0001641172-25-003021
Insider Transaction Report
Form 4
CHAN FAI
Director10% Owner
Transactions
- Sale
Common stock
2025-04-03$0.49/sh−351,555$174,020→ 0 total(indirect: See footnote)
Footnotes (2)
- [F1]On April 3, 2025, Alset International Limited sold 351,555 shares of the Issuer's common stock at a weighted average sale price of $0.495. This transaction was executed in multiple trades at prices ranging from $0.46 to $0.57. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc.
Documents
Issuer
IMPACT BIOMEDICAL INC.
CIK 0001834105
Entity typeother
Related Parties
1- filerCIK 0001261725
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 5:18 PM ET
- Size
- 5.7 KB